Magnasense AB (FRA:52Q) Short-Term Debt : €0.47 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB Short-Term Debt?

Magnasense AB's Short-Term Debt for the quarter that ended in Dec. 2024 was €0.47 Mil.

Magnasense AB's quarterly Short-Term Debt increased from Jun. 2024 (€0.18 Mil) to Sep. 2024 (€0.29 Mil) and increased from Sep. 2024 (€0.29 Mil) to Dec. 2024 (€0.47 Mil).

Magnasense AB's annual Short-Term Debt declined from Dec. 2022 (€0.48 Mil) to Dec. 2023 (€0.02 Mil) but then increased from Dec. 2023 (€0.02 Mil) to Dec. 2024 (€0.47 Mil).

Magnasense AB Short-Term Debt Historical Data

The historical data trend for Magnasense AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB Short-Term Debt Chart

Magnasense AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

0.48

0.02

0.47

Magnasense AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															0.02	0.18	0.18	0.29	0.47

Magnasense AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Magnasense AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Magnasense AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Magnasense AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (FRA:52Q) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

MAGNA:Sweden

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines